Pharmaceutical giant Roche is currently seeking a highly motivated and
experienced individual to fill the critical role of Disease Area Squad
Lead, focusing specifically on breast cancer within Sub-Saharan Africa.
The position is based in Lagos, Nigeria, and represents a notable
opportunity to impact cancer care in the region.

The Disease Area Squad Lead will be responsible for developing and
executing strategies to improve access to RocheS breast cancer
treatments and solutions across Sub-saharan Africa.This includes
working closely with local stakeholders, healthcare providers, and patient
advocacy groups to address the unique challenges and opportunities in
each market.

Key Responsibilities and Qualifications

While specific details of the role are available on the company’s career
portal, the position typically requires a strong background in sales and
marketing within the pharmaceutical industry, and also a deep
understanding of the breast cancer landscape in Sub-Saharan Africa.
Candidates are expected to possess excellent leadership, dialog,
and strategic thinking skills.

“The Disease Area Squad Lead will be responsible for developing and
executing strategies to improve access to Roche’s breast cancer
treatments.”

the role also necessitates a proven track record of successfully launching
and promoting pharmaceutical products, as well as building strong
relationships with key opinion leaders and decision-makers. A relevant
advanced degree, such as an MBA or PharmD, is frequently enough preferred.

Impact on Breast Cancer Care in Sub-Saharan Africa

Breast cancer is a significant health challenge in Sub-Saharan Africa,
with incidence rates steadily rising in many countries. Limited access to
early detection, diagnosis, and treatment contributes to poorer outcomes
compared to developed nations.

By focusing on this critical area, the Disease area Squad Lead will play
a vital role in improving the lives of women affected by breast cancer
across the region. This includes working to increase awareness of the
disease, improve access to screening and diagnostic services, and ensure
that patients receive the most appropriate and effective treatments
available.